Jayaraman Sivaraman

Dr. Jayaraman Sivaraman


Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2013 in Protein Science
Verified
Journal Article
Closed access
PDF file
VCVishnu Priyanka Reddy Chichili
Vishnu Priyanka Reddy Chichili
VKVeerendra Kumar
Veerendra Kumar
JSJayaraman Sivaraman
Jayaraman Sivaraman

1 September 2007 in Biochemical Pharmacology
Verified
Journal Article
Closed access
PDPrerna Domadia
Prerna Domadia
SSSanjay Swarup
Sanjay Swarup
ABAnirban Bhunia
Anirban Bhunia
JSJayaraman Sivaraman
Jayaraman Sivaraman
DDDebjani Dasgupta
Debjani Dasgupta

15 February 2008 in Biochemistry
Verified
Journal Article
Closed access
PDPrerna N. Domadia
Prerna N. Domadia
ABAnirban Bhunia
Anirban Bhunia
JSJayaraman Sivaraman
Jayaraman Sivaraman
SSSanjay Swarup
Sanjay Swarup
DDDebjani Dasgupta
Debjani Dasgupta

26 April 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
KTK. Thangavelu
K. Thangavelu
CPCatherine Qiurong Pan
Catherine Qiurong Pan
TKTobias Karlberg
Tobias Karlberg
GBGanapathy Balaji
Ganapathy Balaji
MUMahesh Uttamchandani
Mahesh Uttamchandani
JSJayaraman Sivaraman
Jayaraman Sivaraman
Besides thriving on altered glucose metabolism, cancer cells undergo glutaminolysis to meet their energy demands. As the first enzyme in catalyzing glutaminolysis, human kidney-type glutaminase isoform (KGA) is becoming an attractive target for small molecules such as BPTES [bis-2-(5 phenylacetamido-1, 2, 4-thiadiazol-2-yl) ethyl sulfide], although the regulatory mechanism of KGA remains unknown. On the basis of crystal structures, we reveal that BPTES binds to an allosteric pocket at the dimer interface of KGA, triggering a dramatic conformational change of the key loop (Glu312-Pro329) near the catalytic site and rendering it inactive. The binding mode of BPTES on the hydrophobic pocket explains its specificity to KGA. Interestingly, KGA activity in cells is stimulated by EGF, and KGA associates with all three kinase components of the Raf-1/Mek2/Erk signaling module. However, the enhanced activity is abrogated by kinase-dead, dominant negative mutants of Raf-1 (Raf-1-K375M) and Mek2 (Mek2-K101A), protein phosphatase PP2A, and Mek-inhibitor U0126, indicative of phosphorylation-dependent regulation. Furthermore, treating cells that coexpressed Mek2-K101A and KGA with suboptimal level of BPTES leads to synergistic inhibition on cell proliferation. Consequently, mutating the crucial hydrophobic residues at this key loop abrogates KGA activity and cell proliferation, despite the binding of constitutive active Mek2-S222/226D. These studies therefore offer insights into ( i ) allosteric inhibition of KGA by BPTES, revealing the dynamic nature of KGA's active and inhibitory sites, and ( ii ) cross-talk and regulation of KGA activities by EGF-mediated Raf-Mek-Erk signaling. These findings will help in the design of better inhibitors and strategies for the treatment of cancers addicted with glutamine metabolism.

1 January 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
QSQingxiang Sun
Qingxiang Sun
RCRuairi Collins
Ruairi Collins
SHShufen Huang
Shufen Huang
LHLovisa Holmberg-Schiavone
Lovisa Holmberg-Schiavone
GAGanesh S. Anand
Ganesh S. Anand
JSJayaraman Sivaraman
Jayaraman Sivaraman
Impairment of the formation or action of hydrogen sulfide (H2S), an endogenous gasotransmitter, is associated with various diseases, such as hypertension, diabetes mellitus, septic and hemorrhagic shock, and pancreatitis. Cystathionine β-synthase and cystathionine γ-lyase (CSE) are two pyridoxal-5′-phosphate (PLP)-dependent enzymes largely responsible for the production of H2S in mammals. Inhibition of CSE by dl-propargylglycine (PAG) has been shown to alleviate disease symptoms. Here we report crystal structures of human CSE (hCSE), in apo form, and in complex with PLP and PLP·PAG. Structural characterization, combined with biophysical and biochemical studies, provides new insights into the inhibition mechanism of hCSE-mediated production of H2S. Transition from the open form of apo-hCSE to the closed PLP-bound form reveals large conformational changes hitherto not reported. In addition, PAG binds hCSE via a unique binding mode, not observed in PAG-enzyme complexes previously. The interaction of PAG-hCSE was not predicted based on existing information from known PAG complexes. The structure of hCSE·PLP·PAG complex highlights the particular importance of Tyr114 in hCSE and the mechanism of PAG-dependent inhibition of hCSE. These results provide significant insights, which will facilitate the structure-based design of novel inhibitors of hCSE to aid in the development of therapies for diseases involving disorders of sulfur metabolism.

1 May 2008 in Journal of Virology
Verified
Journal Article
Closed access
JSjiahai shi
jiahai shi
JSJayaraman Sivaraman
Jayaraman Sivaraman
JSJianxing Song
Jianxing Song
Unlike 3C protease, the severe acute respiratory syndrome coronavirus (SARS-CoV) 3C-like protease (3CLpro) is only enzymatically active as a homodimer and its catalysis is under extensive regulation by the unique extra domain. Despite intense studies, two puzzles still remain: (i) how the dimer-monomer switch is controlled and (ii) why dimerization is absolutely required for catalysis. Here we report the monomeric crystal structure of the SARS-CoV 3CLpro mutant R298A at a resolution of 1.75 Å. Detailed analysis reveals that Arg298 serves as a key component for maintaining dimerization, and consequently, its mutation will trigger a cooperative switch from a dimer to a monomer. The monomeric enzyme is irreversibly inactivated because its catalytic machinery is frozen in the collapsed state, characteristic of the formation of a short 310-helix from an active-site loop. Remarkably, dimerization appears to be coupled to catalysis in 3CLpro through the use of overlapped residues for two networks, one for dimerization and another for the catalysis.